Medtronic Neuro Biz Stimulation Prospects Include Epilepsy, OCD Treatments
This article was originally published in The Gray Sheet
Executive Summary
The potential of Medtronic's deep brain stimulation technology to treat epilepsy will be evaluated in a 10-center, 124-patient pivotal trial
You may also be interested in...
Cyberonics Faces Challenge Of Expectations In Wake Of Failed Medtronic Bid
Cyberonics likely will face increased pressure to execute its long term business plan and meet rising shareholder expectations now that Medtronic's unwelcome $480 mil. acquisition proposal has been withdrawn.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.